Guo H - Search Results

1

[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‑1 degradation via the ubiquitin‑proteasome pathway.

Yao J, Xu T, Tian T, Fu X, Wang W, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y. Yao J, et al. Among authors: guo h. Oncol Rep. 2024 Jul;52(1):89. doi: 10.3892/or.2024.8748. Epub 2024 May 17. Oncol Rep. 2024. PMID: 38757398 Free PMC article.

2

Rapamycin improves Graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytes.

Zhang M, Chong KK, Chen ZY, Guo H, Liu YF, Kang YY, Li YJ, Shi TT, Lai KK, He MQ, Ye K, Kahaly GJ, Shi BY, Wang Y. Zhang M, et al. Among authors: guo h. JCI Insight. 2023 Feb 8;8(3):e160377. doi: 10.1172/jci.insight.160377. JCI Insight. 2023. PMID: 36580373 Free PMC article.

3

Perioperative immunotherapy for nonsmall cell lung cancer.

Huang J, Li W, Guo H. Huang J, et al. Among authors: guo h. Curr Opin Oncol. 2025 Jan 1;37(1):63-72. doi: 10.1097/CCO.0000000000001100. Epub 2024 Sep 25. Curr Opin Oncol. 2025. PMID: 39352274 Review.

4

Association of insulin-like growth factor-1 with thyroid nodules.

Liu YJ, Qiang W, Liu XJ, Xu L, Guo H, Wu LP, Shi B. Liu YJ, et al. Among authors: guo h. Oncol Lett. 2011 Nov;2(6):1297-1301. doi: 10.3892/ol.2011.411. Epub 2011 Sep 2. Oncol Lett. 2011. PMID: 22848305 Free PMC article.

5

Unusual presentation of two Chinese phenylketonuria sisters who were misdiagnosed for years.

Liu X, Guo H, Dahal M, Shi B. Liu X, et al. Among authors: guo h. BMJ Case Rep. 2013 Sep 24;2013:bcr2013010270. doi: 10.1136/bcr-2013-010270. BMJ Case Rep. 2013. PMID: 24068375 Free PMC article.

6

Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves' hyperthyroidism.

He Y, Liu S, Guo H, Shi B. He Y, et al. Among authors: guo h. BMJ Case Rep. 2014 May 30;2014:bcr2013203436. doi: 10.1136/bcr-2013-203436. BMJ Case Rep. 2014. PMID: 24879726 Free PMC article.

7

SGLT-2 as a potential target in pancreatic cancer: the preliminary clue from The Cancer Genome Atlas data.

Qiang W, Lei Y, Yuan L, Yuan J, Zhang J, Shan Y, Tian H, Shi B, Guo H. Qiang W, et al. Among authors: guo h. J Gastrointest Oncol. 2022 Oct;13(5):2539-2552. doi: 10.21037/jgo-22-900. J Gastrointest Oncol. 2022. PMID: 36388652 Free PMC article.

8

Metformin suppresses NFE2L1 pathway activation to inhibit gap junction beta protein expression in NSCLC.

Yu S, Ren H, Liu T, Han X, Guo H, Ning Q, Li Y, Zhou H, Chen M, Hu T. Yu S, et al. Among authors: guo h. Cancer Med. 2024 Apr;13(7):e7021. doi: 10.1002/cam4.7021. Cancer Med. 2024. PMID: 38562019 Free PMC article.

9

SGLT-2 inhibitors and high-dose acarbose as potential high-risk combinations for ketosis and ketoacidosis in Asian patients with T2DM: A case series.

Qiang W, Yang F, Liu L, Dong R, Sun Y, Mondal A, Guo H. Qiang W, et al. Among authors: guo h. Clin Case Rep. 2024 Sep 11;12(9):e9282. doi: 10.1002/ccr3.9282. eCollection 2024 Sep. Clin Case Rep. 2024. PMID: 39267955 Free PMC article.

10

Comment on "Stereotactic Body Radiotherapy for Centrally Located Inoperable Early-Stage NSCLC: EORTC 22113-08113 LungTech Phase II Trial Results".

Xu Z, Jiang J, Guo H, Zhao D, Liu S. Xu Z, et al. Among authors: guo h. J Thorac Oncol. 2024 Oct;19(10):e56-e57. doi: 10.1016/j.jtho.2024.07.013. J Thorac Oncol. 2024. PMID: 39370227 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,210 results

Search Page

Filters